| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 17,999 | $9.15 | $164,690.85 | - | +13.7% | +83.9% | |
| Dec 12, 2023 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 950 | $12.45 | $11,827.50 | +5.7% | +34.0% | +7.8% | |
| Dec 12, 2023 | DCTH Delcath Systems, Inc. | Vukovic Vojo | Chief Medical Officer | Buy | 40,000 | $3.00 | $120,000.00 | +66.7% | +24.0% | +292.0% | |
| Dec 12, 2023 | DXCM Dexcom Inc | Altman Steven R60 | Director | Sell | 3,000 | $120.00 | $360,004.20 | -5.0% | +11.6% | -32.5% | |
| Dec 12, 2023 | APYX Apyx Medical Corp | Hill Matthew C | Chief Financial Officer | Buy | 2,500 | $2.19 | $5,475.00 | New | -20.2% | -15.1% | |
| Dec 12, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $42.03 | $420,303.50 | -2.6% | +1.2% | +29.3% | |
| Dec 11, 2023 | HOLX Hologic Inc | Garrett Scott T | Director | Sell | 10,000 | $68.71 | $687,116.00 | -17.5% | +11.1% | +11.9% | |
| Dec 11, 2023 | AXGN Axogen, Inc. | Mariani Peter J65 | EVP &Chief Financial Officer | Sell | 12,500 | $7.50 | $93,809.40 | -5.6% | +11.8% | +96.6% | |
| Dec 11, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 90,118 | $9.36 | $843,504.48 | +0.2% | +16.3% | +81.6% | |
| Dec 11, 2023 | BDX Becton Dickinson & Co | Garrison Michael David67 | EVP &President Medical | Sell | 1,239 | $232.46 | $288,017.94 | -14.6% | +3.0% | -3.5% | |
| Dec 11, 2023 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources Offi | Sell | 392 | $117.66 | $46,122.72 | -0.5% | +12.8% | -32.6% | |
| Dec 11, 2023 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 22,288 | $54.42 | $1,212,806.08 | -0.5% | +19.1% | +82.7% | |
| Dec 11, 2023 | RXST Rxsight, Inc. | Warner Robert Keith | Director | Sell | 20,000 | $35.03 | $700,551.42 | -27.4% | +43.8% | +11.8% | |
| Dec 11, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,369 | $1.10 | $6,979.14 | - | +6.2% | -45.0% | |
| Dec 11, 2023 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 29,310 | $11.19 | $328,046.60 | -7.2% | +4.7% | +106.2% | |
| Dec 8, 2023 | MYO Myomo, Inc. | Crowley Thomas Aloysius Jr.80 | Director | Sell | 14,997 | $0.00 | - | -33.3% | -11.6% | +51.3% | |
| Dec 8, 2023 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Office | Sell | 56,038 | $10.56 | $591,761.28 | -99.6% | +16.4% | +122.8% | |
| Dec 8, 2023 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 56,038 | $10.56 | $591,761.28 | -99.8% | +16.4% | +122.8% | |
| Dec 8, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 116,656 | $9.54 | $1,112,898.24 | +0.3% | -0.3% | +108.3% | |
| Dec 8, 2023 | DCTH Delcath Systems, Inc. | Michel Gerard J47 | Chief Executive Officer | Buy | 34,000 | $2.94 | $99,960.00 | +14.9% | +33.9% | +298.3% | |
| Dec 8, 2023 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 50,995 | $54.62 | $2,785,266.55 | -0.7% | +25.6% | +85.0% | |
| Dec 8, 2023 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 15,085 | $40.01 | $603,613.16 | -11.3% | +25.3% | +141.2% | |
| Dec 7, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 2,262 | $1.07 | $2,430.29 | - | +14.6% | -43.6% | |
| Dec 7, 2023 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 5,000 | $4.80 | $24,000.00 | -2.5% | +79.4% | +45.5% | |
| Dec 7, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 74,852 | $9.19 | $687,889.88 | +0.2% | -0.2% | +111.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.